Prion (PrPSc)-specific epitope defined by a monoclonal antibody

Area of Science:

• Neuroscience
• Biochemistry
• Immunology

Background:

• Prions cause transmissible spongiform encephalopathies (TSEs) by misfolding cellular prion protein (PrPC) into disease-associated forms (PrPSc).
• PrPSc exhibits distinct structural features, including increased beta-sheet content and protease resistance, differentiating it from PrPC.
• Accurate diagnostic tools for TSEs like bovine spongiform encephalopathy (BSE) and Creutzfeldt-Jakob disease (CJD) are crucial.

Purpose of the Study:

• To develop and characterize a monoclonal antibody capable of specifically recognizing the disease-associated prion protein (PrPSc).
• To investigate the potential of this antibody for diagnosing prion diseases and understanding prion structure.

Main Methods:

• Development of a monoclonal antibody, designated 15B3.
• Testing 15B3's binding specificity against normal (PrPC) and disease-specific (PrPSc) prion protein forms from various species (bovine, murine, human).
• Mapping the epitope recognized by 15B3 using immobilized synthetic peptides and analyzing its spatial arrangement within the prion protein structure via NMR.

Main Results:

• Monoclonal antibody 15B3 specifically precipitates PrPSc from bovine, murine, and human sources, while not binding to PrPC.
• The 15B3 epitope was mapped to three distinct polypeptide segments within the prion protein.
• Structural analysis suggests these segments are in close spatial proximity in PrPSc, potentially through intermolecular or intramolecular interactions.

Conclusions:

• The monoclonal antibody 15B3 is a valuable tool for discriminating between PrPC and PrPSc, offering a promising avenue for TSE diagnosis.
• The identified epitope's structure in PrPSc provides insights into the conformational changes underlying prion diseases.
• Further research into the 15B3 epitope's role in PrPSc formation could enhance our understanding of prion infectivity.